CDTX
Cidara Therapeutics Inc
NASDAQ: CDTX · HEALTHCARE · BIOTECHNOLOGY
$221.38
+0.00% today
Updated 2026-01-07
Market cap
$6.96B
P/E ratio
—
P/S ratio
4,540.70x
EPS (TTM)
$-11.20
Dividend yield
—
52W range
$15 – $221
Volume
1.5M
Cidara Therapeutics Inc (CDTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | $-1.05M | $-7.71M | $-25.96M | $-39.77M | $-49.91M | $-56.70M | $-28.53M | $-54.41M | $-25.23M | $-28.47M | $-22.43M | $-176.53M |
| Capital expenditures | $0.00 | $0.00 | $991000.00 | $1.17M | $401000.00 | $306000.00 | $177000.00 | $35000.00 | $186000.00 | $41000.00 | $118000.00 | $505000.00 | $129000.00 |
| Depreciation | — | — | $179000.00 | $461000.00 | $732000.00 | $667000.00 | $523000.00 | $375000.00 | $229000.00 | $-1.23M | $143000.00 | $118000.00 | $233000.00 |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free cash flow | — | $-1.05M | $-8.70M | $-27.13M | $-40.17M | $-50.22M | $-56.88M | $-28.57M | $-54.60M | $-25.27M | $-28.59M | $-22.94M | $-176.66M |
| Investing cash flow | — | — | $-991000.00 | $-46.09M | $25.48M | $4.47M | $14.30M | $-35000.00 | $-186000.00 | $-41000.00 | $-118000.00 | $-505000.00 | $-129000.00 |
| Financing cash flow | $12000.00 | $1.23M | $31.31M | $111.81M | $37.09M | $20.88M | $56.15M | $14.27M | $37.28M | $44.60M | $-951000.00 | $25.98M | $337.06M |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $39.77M | $22.80M | $-24.55M | $13.75M | $-14.29M | $-17.32M | — | $-29.54M | — | — |